Anzeige
Mehr »
Login
Dienstag, 05.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
300% Aktienanstieg war nur der Vorgeschmack – Warum diese Kupferstory noch besser wird!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
459 Leser
Artikel bewerten:
(2)

Hydro Hotel Eastbourne Plc - Interim Results for the Half Year ended 30 April 2023

Hydro Hotel Eastbourne Plc - Interim Results for the Half Year ended 30 April 2023

PR Newswire

LONDON, United Kingdom, July 12

12 July 2023

Hydro Hotel, Eastbourne, Plc

("Hydro Hotel" or the "Company")

Interim Results for the Half Year ended 30 April 2023

YOUR CHAIRMAN'S LETTER

Dear Shareholder,

SIX MONTHS TO 30 APRIL 2023

I am pleased to report on the company's results for the six months to 30 April 2023. The total turnover for the six month period to 30 April 2023 was £1,799,816 compared to £1,822,411 for the same period the previous year, a decrease of 1% (compared to an increase in the six months to 30 April 2022 of 882%).

The gross profit percentage for the period was 3% lower than in the six months to 30 April 2022 and staff costs (excluding grants received for the Coronavirus Job Retention Scheme) increased by 3% compared to the figure for the period to 30 April 2022 (73% increase in the half year to 30 April 2022).

Overheads increased by 17% (77% increase in the half year ended 30 April 2022). Essential repair work to the fabric of the building was undertaken during the six months to 30 April 2023, with only routine maintenance carried out during the period to 30 April 2022. Consequently, there was an increase in repair costs of £83,847 for this period compared to the same period in the previous year, contributing to the increase in overhead expenses. This in turn has led to a loss for the half year to 30 April 2023 of £171,469 compared to a profit of £22,277 for the half year to 30 April 2022.

The updating of the décor and furniture of the Crystal Restaurant continued during the period, together with the refurbishment of some bedrooms and public areas. New solar panels were installed on the hotel roof, to save energy costs and in keeping with the company's green policy.

The Board and the management of the company continue to monitor cash resources and have paid the dividend of £138,000 declared on 19 January 2023. No further dividends were declared in the period.

The Board wishes to express its thanks to the management and staff of the hotel for their co-operation and efforts during the period. The Hydro team look forward to welcoming new and returning guests in this our 128th year of operation.

Yours sincerely,

Graeme C King, MA, CA

11 July 2023

STATEMENT OF COMPREHENSIVE INCOME FOR THE HALF YEAR ENDED 30 APRIL 2023

Half year to

Half year to

Year ended

30 April 2023

30 April 2022

31 October 2022

(Unaudited)

(Unaudited)

(Audited)

£

£

£

TURNOVER

1,799,816

1,822,411

4,402,288

OPERATING (LOSS)/PROFIT

(192,313)

17,580

429,300

INTEREST RECEIVABLE

20,844

4,697

15,911

(LOSS)/PROFIT BEFORE TAXATION

(171,469)

22,277

445,211

TAXATION

-

-

(108,511)

(LOSS)/PROFIT FOR PERIOD

£(171,469)

£22,277

£336,700

(Loss)/Earnings per share

(28.58)p

3.71p

56.12p

STATEMENT OF FINANCIAL POSITION AT 30 APRIL 2023

30 April 2023

30 April 2022

31 October 2022

(Unaudited)

(Unaudited)

(Audited)

£

£

£

FIXED ASSETS

Tangible Assets

2,565,055

2,504,821

2,456,700

CURRENT ASSETS

Stocks

40,321

40,200

36,645

Debtors

156,803

124,131

214,131

Investments - 3 month notice deposit accounts

459,798

451,946

453,924

Cash at bank and in hand

1,146,320

1,353,406

1,585,647

1,803,242

1,969,683

2,290,347

CREDITORS

Amounts falling due within one year

(761,721)

(817,611)

(831,002)

NET CURRENT ASSETS

1,041,521

1,152,072

1,459,345

TOTAL ASSETS LESS

CURRENT LIABILITIES

3,606,576

3,656,893

3,916,045

PROVISION FOR LIABILITIES

(123,109)

(94,380)

(123,109)

NET ASSETS

£3,483,467

£3,562,513

£3,792,936

CAPITAL AND RESERVES

Called up share capital

600,000

600,000

600,000

Revaluation reserve

398,372

402,651

398,372

Profit and loss reserves

2,485,095

2,559,862

2,794,564

£3,483,467

£3,562,513

£3,792,936



STATEMENT OF CASH FLOWS FOR THE HALF YEAR ENDED 30 APRIL 2023

Half year to

Half year to

Year ended

30 April 2023

30 April 2022

31 October 2022

(Unaudited)

(Unaudited)

(Audited)

£

£

£

NET CASH (USED IN)/INFLOW FROM

OPERATING ACTIVITIES (Note 1)

(133,517)

238,289

597,959

NET CASH (USED IN) INVESTING

ACTIVITIES (Note 2)

(167,810)

(93,236)

(136,665)

FINANCING ACTIVITIES

Dividends paid

(138,000)

(120,000)

(204,000)

NET (DECREASE)/INCREASE IN CASH AND

CASH EQUIVALENTS

(439,327)

25,053

257,294

CASH AND CASH EQUIVALENTS AT THE

BEGINNING OF THE PERIOD

1,585,647

1,328,353

1,328,353

CASH AND CASH EQUIVALENTS AT THE

END OF THE PERIOD

£1,146,320

£1,353,406

£1,585,647

RELATING TO:

Cash at bank and in hand

£1,146,320

£1,353,406

£1,585,647




NOTES TO THE STATEMENT OF CASH FLOWSFOR THE HALF YEAR ENDED 30 APRIL 2023

Half year to

Half year to

Year ended

30 April 2023

30 April 2022

31 October 2022

(Unaudited)

(Unaudited)

(Audited)

£

£

£

Note 1

CASH FLOWS FROM OPERATING

ACTIVITIES

(Loss)/profit after tax

(171,469)

22,277

336,700

Adjustments for:

Taxation

-

-

108,511

Depreciation

95,450

92,102

192,714

Loss/(gain) on disposal of fixed assets

3,625

289

463

Interest receivable

(20,844)

(4,697)

(15,911)

OPERATING CASH FLOW BEFORE

WORKING CAPITAL CHANGES

(93,238)

109,971

622,477

MOVEMENTS IN WORKING CAPITAL

(Increase)/decrease in stocks

(3,676)

(3,543)

12

Decrease/(increase) in debtors

57,328

(8,459)

(98,459)

(Decrease)/increase in creditors

(93,931)

140,320

183,783

Income taxes paid

-

-

(109,854)

NET CASH (USED IN)/GENERATED FROM

OPERATING ACTIVITIES

£(133,517)

£238,289

£597,959

Note 2

INVESTING ACTIVITIES

Purchase of tangible fixed assets

(182,780)

(97,001)

(149,666)

Interest received

20,844

4,697

15,911

Payment for other investments

(5,874)

(932)

(2,910)

NET CASH FLOW (USED IN) INVESTING

ACTIVITIES

£(167,810)

£(93,236)

£(136,665)

NOTES TO THE ACCOUNTS

1

The results are prepared on the basis of the accounting policies set out in the Company's Annual Report and Accounts for the year ended 31 October 2022.

2

The earnings per share are based on a loss of £171,469 (2022 profit of £22,277) being the loss on ordinary activities after taxation.

3

The movement in retained Profit and Loss Reserves from £2,794,564 at 31 October 2022 to £2,485,095 at 30 April 2023 includes the loss for the period and dividends paid of £138,000 (2022: £120,000 paid in the period and £Nil accrued).

4

All dividends in 2023 were paid in the period and no accrual is included in creditors, amounts falling due within one year as at 30 April 2023 (2022: £120,000 dividends paid and no accrual included in creditors, amounts falling due within one year as at 30 April 2022).

5

A copy of the interim report and accounts and the Chairman's statement thereto, which were approved by the Board of Directors on 11 July 2023, will be posted to all registered shareholders shortly thereafter.

6

The financial information set out above does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 October 2022, on which the report of the auditor was unqualified and did not contain a statement under section 498 of the Companies Act 2006, have been filed with the Registrar of Companies.

7

The company's auditor, UHY Hacker Young LLP, has not reviewed these unaudited interim accounts.

Enquiries:

Hydro Hotel, Eastbourne, Plc

Sally Gausden

Company Secretary

Telephone: +44 1323 431 200

Peterhouse Capital Limited

AQSE Corporate Adviser

Mark Anwyl

Telephone: +44 20 7469 0930

Market Abuse Regulation (MAR) Disclosure

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).




© 2023 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.